Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash $ 374,360 $ 1,305,748
Prepaid expenses and other current assets 65,978 62,317
Total current assets 440,338 1,368,065
Prepaid expense, less current portion 4,587
Total assets 444,925 1,368,065
Current liabilities:    
Accounts payable and accrued expenses 396,593 312,034
Research and development contract liabilities 62,440 60,990
Total current liabilities 459,033 373,024
Commitments and contingencies
Stockholders' equity (deficiency):    
Preferred Stock, $0.0001 par value; authorized - 10,000,000 shares; issued and outstanding - 350,000 shares of Series A Convertible Preferred Stock, $10.00 per share stated value, $50.00 per share cash redemption value; aggregate cash redemption value - $17,500,000; liquidation preference based on assumed conversion into common shares - 4,375,000 shares 3,500,000 3,500,000
Common stock, $0.0001 par value; authorized - 100,000,000 shares; issued and outstanding - 58,045,814 shares and 58,025,814 shares at September 30, 2018 and December 31, 2017, respectively 5,804 5,802
Additional paid-in capital 20,780,042 20,004,654
Accumulated deficit (24,299,954) (22,515,415)
Total stockholders' equity (deficiency) (14,108) 995,041
Total liabilities and stockholders' equity (deficiency) $ 444,925 $ 1,368,065